Your browser is no longer supported. Please, upgrade your browser.
Settings
BLFS BioLife Solutions, Inc. daily Stock Chart
BLFS [NASD]
BioLife Solutions, Inc.
Index- P/E- EPS (ttm)-0.46 Insider Own1.70% Shs Outstand12.93M Perf Week7.18%
Market Cap65.69M Forward P/E- EPS next Y-0.05 Insider Trans0.00% Shs Float6.47M Perf Month8.55%
Income-5.90M PEG- EPS next Q-0.06 Inst Own2.60% Short Float6.92% Perf Quarter116.17%
Sales9.30M P/S7.06 EPS this Y-57.10% Inst Trans28.22% Short Ratio2.63 Perf Half Y155.28%
Book/sh0.52 P/B9.77 EPS next Y79.20% ROA-66.30% Target Price5.42 Perf Year177.60%
Cash/sh- P/C- EPS next 5Y- ROE-125.20% 52W Range1.43 - 5.91 Perf YTD215.48%
Dividend- P/FCF- EPS past 5Y-6.70% ROI-80.90% 52W High-14.04% Beta-0.83
Dividend %- Quick Ratio3.70 Sales past 5Y24.40% Gross Margin60.40% 52W Low254.56% ATR0.33
Employees35 Current Ratio5.40 Sales Q/Q30.00% Oper. Margin-27.70% RSI (14)63.85 Volatility9.14% 6.85%
OptionableNo Debt/Eq0.00 EPS Q/Q45.70% Profit Margin-63.70% Rel Volume0.48 Prev Close5.02
ShortableYes LT Debt/Eq0.00 EarningsAug 10 AMC Payout- Avg Volume170.10K Price5.08
Recom1.30 SMA206.00% SMA5023.29% SMA20098.98% Volume81,426 Change1.20%
Sep-19-17Reiterated Maxim Group Buy $6 → $7
Jul-05-17Upgrade Janney Neutral → Buy $5
Mar-10-17Reiterated Maxim Group Buy $3 → $4
Jan-19-17Initiated Maxim Group Buy $3
Sep-19-17 06:30AM  BioLife Solutions CryoStor® Cell Freeze Media Embedded in Cellular Biomedicine Group Clinical Trial of AlloJoin PR Newswire
Sep-07-17 06:30AM  BioLife Solutions to Present at September Investment Conferences PR Newswire
Sep-05-17 06:58AM  Novartis CAR-T therapy was the first approved in U.S. heres how to invest in the space MarketWatch
Aug-11-17 06:43PM  Edited Transcript of BLFS earnings conference call or presentation 10-Aug-17 8:30pm GMT Thomson Reuters StreetEvents +5.56%
Aug-10-17 04:05PM  BioLife Solutions Announces Second Quarter 2017 Financial Results PR Newswire
12:30PM  Investor Network: BIOLIFE SOLUTIONS INC to Host Earnings Call ACCESSWIRE
Aug-03-17 06:30AM  BioLife Solutions to Report Second Quarter 2017 Financial Results and Provide Business Update on August 10, 2017 PR Newswire
Aug-02-17 07:30AM  Featured Company News BioLife Solutions Executes Supply Agreement with Celyad for CryoStor(R) Use in Natural Killer Receptor based T-Cell (NKR-T) Platform ACCESSWIRE +6.61%
Jul-31-17 06:30AM  BioLife Solutions Executes Supply Agreement with Celyad for CryoStor® Use in Natural Killer Receptor based T-Cell (NKR-T) Platform Targeting Solid Tumors and Blood Cancers PR Newswire
Jul-13-17 04:05PM  BioLife Solutions CryoStor® Cell Freeze Media Embedded in Invossa: First Approved Cell and Gene Therapy for Osteoarthritis PR Newswire +8.55%
Jul-07-17 02:37PM  ETFs with exposure to BioLife Solutions, Inc. : July 7, 2017 Capital Cube
Jul-05-17 06:00AM  BioLife Solutions Modifies Existing Credit Facility PR Newswire +10.69%
Jun-14-17 06:00AM  BioLife Solutions Executes Supply Agreement with Adaptimmune for CryoStor® Use in SPEAR T-Cell Platform PR Newswire
Jun-01-17 01:39PM  ETFs with exposure to BioLife Solutions, Inc. : June 1, 2017 Capital Cube
May-22-17 01:24PM  ETFs with exposure to BioLife Solutions, Inc. : May 22, 2017 Capital Cube
May-19-17 10:05AM  BioLife Solutions, Inc. :BLFS-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017 Capital Cube
May-16-17 09:44AM  Edited Transcript of BLFS earnings conference call or presentation 11-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-11-17 04:05PM  BioLife Solutions Announces Q1 2017 Financial Results PR Newswire
03:00PM  Investor Network: BIOLIFE SOLUTIONS INC to Host Earnings Call Accesswire
May-04-17 06:30AM  BioLife Solutions to Report First Quarter 2017 Financial Results and Provide Business Update on May 11, 2017 PR Newswire
Apr-20-17 02:14PM  ETFs with exposure to BioLife Solutions, Inc. : April 20, 2017 Capital Cube
Apr-05-17 04:25PM  ETFs with exposure to BioLife Solutions, Inc. : April 5, 2017 Capital Cube
Mar-21-17 01:04PM  BIOLIFE SOLUTIONS INC Financials
Mar-20-17 09:27AM  BioLife Solutions, Inc. :BLFS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Capital Cube
Mar-17-17 10:03AM  BioLife Solutions, Inc. :BLFS-US: Earnings Analysis: 2016 By the Numbers : March 17, 2017
Mar-15-17 05:27PM  BIOLIFE SOLUTIONS INC Files SEC form 10-K, Annual Report
Mar-09-17 04:53PM  BIOLIFE SOLUTIONS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
04:05PM  BioLife Solutions Reports 4th Quarter and Full Year 2016 Results PR Newswire
07:07AM  Q4 2016 BioLife Solutions Inc Earnings Release - After Market Close
Mar-03-17 06:05AM  BIOLIFE SOLUTIONS INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Bal +5.47%
Mar-02-17 04:30PM  BioLife Solutions to Report Fourth Quarter and Full Year 2016 Financial Results and Provide Business Update on March 9, 2017 PR Newswire
Feb-16-17 09:19AM  BIOLIFE SOLUTIONS INC Files SEC form 8-K, Regulation FD Disclosure
Feb-14-17 05:00AM  SAVSU Technologies Provides Performance Update on evo® Cold Chain 2.0 System in ImmunoCellular Therapeutics Phase 3 Glioblastoma Cell Therapy Clinical Trial PR Newswire -6.67%
Jan-20-17 12:56PM  ETFs with exposure to BioLife Solutions, Inc. : January 20, 2017 Capital Cube
Jan-19-17 07:42AM  Coverage initiated on BioLife Solutions by Maxim Group
Jan-13-17 06:02AM  BIOLIFE SOLUTIONS INC Files SEC form 8-K, Results of Operations and Financial Condition, Creation of a Direct Financi
Jan-12-17 06:00AM  BioLife Solutions Announces 2016 Revenue Growth of 28% PR Newswire
Jan-10-17 06:00AM  BioLife Solutions Amends Existing Credit Facility PR Newswire +9.95%
Jan-04-17 06:46AM  BIOLIFE SOLUTIONS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Stateme
Jan-03-17 04:17PM  BioLife Solutions Restructures biologistex Joint Venture PR Newswire
Dec-20-16 06:00AM  BioLife Solutions Executes 10 Year Supply Agreement with TissueGene for CryoStor® Use in Invossa Osteoarthritis Cell-Mediated Gene Therapy PR Newswire +7.67%
Dec-13-16 12:32PM  ETFs with exposure to BioLife Solutions, Inc. : December 13, 2016
Dec-09-16 04:13PM  BIOLIFE SOLUTIONS INC Files SEC form 10-K/A, Annual Report
Dec-06-16 06:03AM  BIOLIFE SOLUTIONS INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Bal
Nov-16-16 12:50PM  ETFs with exposure to BioLife Solutions, Inc. : November 16, 2016
Nov-15-16 11:52AM  BioLife Solutions, Inc. :BLFS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 15, 2016
Nov-14-16 04:59PM  Biolife Solutions posts record Q3 revenue at bizjournals.com
12:03AM  Edited Transcript of BLFS earnings conference call or presentation 10-Nov-16 9:30pm GMT
Nov-10-16 04:08PM  BIOLIFE SOLUTIONS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh +6.71%
04:05PM  BioLife Solutions Reports Record Results for Third Quarter 2016 PR Newswire
07:07AM  Q3 2016 BioLife Solutions Inc Earnings Release - After Market Close
Nov-03-16 06:00AM  BioLife Solutions to Report Third Quarter 2016 Financial Results and Provide Business Update on November 10, 2016 PR Newswire
Oct-26-16 06:00AM  BioLife Solutions and Brooks Life Sciences Partner on Study of Best Practices for Shipping and Storing Time and Temperature Sensitive Biologic Materials PR Newswire
Oct-06-16 04:32PM  BIOLIFE SOLUTIONS INC Files SEC form 8-K, Change in Directors or Principal Officers
Sep-15-16 06:00AM  BioLife Solutions' CryoStor® Embedded in Manufacturing Process for Promethera Biosciences HepaStem Cell-Based Treatment for Liver Disorders PR Newswire
Sep-07-16 06:03AM  BIOLIFE SOLUTIONS INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Bal
Aug-25-16 12:12PM  These 5 Stocks Under $10 Could Make You a Lot of Money
Aug-24-16 06:00AM  BioLife Solutions' CryoStor® Integrated in Kolon Group's Cell-Mediated Gene Therapy for Osteoarthritis PR Newswire +5.49%
Aug-16-16 12:05PM  ETFs with exposure to BioLife Solutions, Inc. : August 16, 2016 -5.42%
Aug-15-16 02:03PM  BioLife Solutions, Inc. :BLFS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016
Aug-12-16 11:47AM  Edited Transcript of BLFS earnings conference call or presentation 11-Aug-16 8:30pm GMT
Aug-11-16 04:07PM  BIOLIFE SOLUTIONS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
04:05PM  BioLife Solutions Reports Results for Second Quarter 2016 PR Newswire
07:07AM  Q2 2016 BioLife Solutions Inc Earnings Release - After Market Close
Aug-10-16 06:00AM  BioLife Solutions Executes 10 Year Supply Agreement with Bellicum Pharmaceuticals for CryoStor® Use in Cellular Immunotherapies PR Newswire
Aug-05-16 03:03PM  ETFs with exposure to BioLife Solutions, Inc. : August 5, 2016
Aug-03-16 06:00PM  BioLife Solutions to Report Second Quarter 2016 Financial Results and Provide Business Update on August 11, 2016 PR Newswire
Jul-22-16 02:58PM  ETFs with exposure to BioLife Solutions, Inc. : July 22, 2016
Jul-18-16 06:00AM  BioLife Solutions Products Embedded in Cook MyoSite® Phase 3 Cell Therapy Clinical Trial for Stress Urinary Incontinence PR Newswire
Jul-13-16 08:52AM  New Reports on Recent Market Movers BioLife, Coherus, GoPro and Lannett Company +8.70%
Jul-12-16 09:31AM  Coverage of Top Gainers Resolute Energy, BioLife Solutions, and Sagent Pharma -12.66%
Jul-11-16 11:07AM  Why Traders Are Clamoring for These 5 Stocks This Morning at Insider Monkey +50.55%
08:53AM  BioLife's stock nearly doubles after supply pact announced at MarketWatch
06:30AM  BioLife Solutions Executes 10 Year Supply Agreement with Kite Pharma for CryoStor® Use in CAR T Cell Therapies PR Newswire
Jun-02-16 06:03AM  BIOLIFE SOLUTIONS INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Bal -5.63%
Jun-01-16 12:44PM  BioLife Solutions, Inc. :BLFS-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016
May-19-16 06:04AM  BIOLIFE SOLUTIONS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
06:00AM  BioLife Solutions and MNX Global Logistics Partner to Support ImmunoCellular Therapeutics with Cold Chain Logistics in ICT-107 Phase 3 Clinical Trial in Glioblastoma PR Newswire
May-18-16 02:00PM  BioLife Solutions Appoints Jim Mathers as New Vice President of Sales PR Newswire
May-16-16 04:07PM  BIOLIFE SOLUTIONS INC Files SEC form 10-Q, Quarterly Report
May-13-16 10:37AM  Edited Transcript of BLFS earnings conference call or presentation 12-May-16 8:30pm GMT
06:04AM  BIOLIFE SOLUTIONS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-12-16 04:30PM  BioLife Solutions Inc Earnings Call scheduled for 4:30 pm ET today
04:21PM  BIOLIFE SOLUTIONS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
04:05PM  BioLife Solutions Reports First Quarter 2016 Results PR Newswire
07:07AM  Q1 2016 BioLife Solutions Inc Earnings Release - After Market Close
May-06-16 06:30AM  BioLife Solutions to Report First Quarter 2016 Financial Results and Provide Business Update on May 12, 2016 PR Newswire
May-04-16 05:03PM  BIOLIFE SOLUTIONS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
06:00AM  BioLife Solutions Names Roderick de Greef Chief Financial Officer & Secretary PR Newswire
May-02-16 08:00AM  MNX Global Logistics and Biologistex, LLC Offer Proactive and Real-time Shipment Monitoring of Time and Temperature Sensitive Biologics, Vaccines & Cell Therapies PR Newswire
06:30AM  Seattle Business Magazine Names BioLife Solutions Washington State Manufacturer of the Year PR Newswire
Apr-26-16 06:00AM  Biologistex LLC and MNX Global Logistics Partner to Offer Enhanced Cold Chain Logistics Services for Time and Temperature Sensitive Biologics, Vaccines & Cell Therapies PR Newswire
Apr-04-16 05:32PM  BIOLIFE SOLUTIONS INC Files SEC form 8-K, Change in Directors or Principal Officers
06:30AM  BioLife Solutions Names Cord Blood Industry Veteran Karen Foster Vice President of Operations PR Newswire
Mar-21-16 12:52PM  BIOLIFE SOLUTIONS INC Files SEC form 8-K, Change in Directors or Principal Officers
Mar-14-16 06:30AM  BioLife Solutions Provides Update on Customer Cell Therapy Clinical Trials and Development Programs PR Newswire
Mar-09-16 06:00AM  BioLife Solutions to Present at 28th Annual ROTH Conference and 4th Annual ARM Cell & Gene Therapy Investor Day PR Newswire
Mar-08-16 06:09AM  BIOLIFE SOLUTIONS INC Files SEC form 8-K, Change in Directors or Principal Officers
Mar-07-16 12:15PM  BioLife Solutions, Inc. :BLFS-US: Earnings Analysis: Q4, 2015 By the Numbers
06:30AM  BioLife Solutions Names Roderick de Greef Interim Chief Financial Officer PR Newswire
BioLife Solutions, Inc. develops, manufactures, and markets patented hypothermic storage and cryopreservation solutions for cells and tissues in the United States. Its products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced, delayed-onset cell damage, and death. The company offers HypoThermosol FRS, a hypothermic storage and shipping media product to mitigate temperature-induced molecular cell stress responses that occur during chilling and re-warming of biologics, intermediate products, and final cell products intended for research and clinical applications; and CryoStor cryopreservation freeze media products, which are designed to mitigate temperature-induced molecular cell stress responses during freezing and thawing. It also provides BloodStor freeze media products, such as BloodStor 55-5 and BloodStor 100 for cryopreservation of stem and other cells isolated from umbilical cord and peripheral blood, and bone marrow; and cell thawing media, which offers Dextran and saline for washing cryopreserved cells and tissues to dilute or remove cryoprotectants. In addition, the company provides custom product formulation and packaging services; contract aseptic manufacturing formulation, fill, and finish services of liquid media products; and precision thermal packaging products and cloud-hosted Web applications. It markets its products to the regenerative medicine, bio-banking, drug discovery markets, comprising hospital-based stem cell transplant centers, pharmaceutical companies, cord blood and adult stem cell banks, hair transplant centers, and suppliers of cells to the drug discovery, toxicology testing, and diagnostic markets. BioLife Solutions, Inc. was founded in 1987 and is headquartered in Bothell, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mathew Aby J.Sr. VP & Chief Tech. OfficerJun 13Option Exercise1.4024,28534,023136,530Jun 14 06:00 AM
GIRSCHWEILER THOMASDirectorFeb 06Option Exercise1.1217,85720,0002,737,054Feb 09 07:39 PM
Hinson Andrew GDirectorFeb 06Option Exercise1.1217,85720,00021,351Feb 09 07:40 PM
Mathew Aby J.Sr. VP & Chief Tech. OfficerFeb 06Option Exercise1.1235,71440,000112,245Feb 09 07:40 PM
COHEN RAYMOND WDirectorFeb 06Option Exercise1.1217,85720,00037,969Feb 09 07:39 PM